(NasdaqGM:NBP), Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint inhibitors, a multi-billion dollar drug class hampered by widespread resistance The Phase 1 ragistomig study achieved its objective, as the new Q6W extended dosing interval produced strong anti-tumor efficacy in PD-L1-non-responders, with an improved safety […]
NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO GlobeNewswire December 04, 2025 Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint inhibitors, a multi-billion dollar drug class hampered by widespread resistance The Phase 1 ragistomig study achieved its objective, as the new
(NYSE:RGNT), Herzliya, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) — Regentis Biomaterials Ltd. (NYSE American: RGNT) (“Regentis”, or the “Company”), a regenerative medicine company dedicated to developing innovative tissue repair solutions that seek to restore the health and enhance the quality of life of patients, today announced the pricing of its initial public offering (the “Offering”)
Simone Biles, Mel Robbins, Martha Stewart and More Spoke at Sold-Out Event Download conference photos here. From a trumpet-toting Diana Nyad leading 11,000 women in a chant of “onward” to Jesse Israel leading them in a meditative sound healing, the dual themes of strength and calm took center stage today at the 2025 Massachusetts Conference
Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering GlobeNewswire December 04, 2025 Herzliya, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) — Regentis Biomaterials Ltd. (NYSE American: RGNT) (“Regentis”, or the “Company”), a regenerative medicine company dedicated to developing innovative tissue repair solutions that seek to restore the health and enhance the quality of life of
(TSX-V:MMY),(Boerse Frankfurt – Freiverkehr:D7Q1.F), VANCOUVER, British Columbia, Dec. 03, 2025 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V: MMY and FSE: D7Q1)(“Monument” or the “Company”) is pleased to announce the first 16 drill hole results from its first BR/Felda mine expansion drilling program and update mine expansion drilling activities at the Selinsing Gold Mine including Selinsing
Monument Announces First 16 Drill Hole Results Of Selinsing Mine Expansion Drilling Program GlobeNewswire December 04, 2025 VANCOUVER, British Columbia, Dec. 03, 2025 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V: MMY and FSE: D7Q1)(“Monument” or the “Company”) is pleased to announce the first 16 drill hole results from its first BR/Felda mine expansion drilling program
Vancouver, British Columbia–(Newsfile Corp. – December 3, 2025) – SPOD LITHIUM CORP. (CSE: SPOD) (OTCQB: SPODF) (the “Company” or “SPOD“) is pleased to announce that it completed the second tranche of its previously announced non-brokered private placement for gross proceeds of $88,000 from the sale of 4,400,000 units (each, a “Unit“) at a price of
LOS ANGELES, Dec. 03, 2025 (GLOBE NEWSWIRE) — Internationally acclaimed, multi-platinum singer-songwriter David Pomeranz delivered an uplifting acoustic performance and book talk that brought a renewed spark to a packed audience. Celebrating the silver anniversary of his album “On This Day,” the performance came on the heels of sold-out concerts in international locations including Abu
David Pomeranz Brings His Signature Magic with Acoustic Performance and Empowerment Message GlobeNewswire December 04, 2025 LOS ANGELES, Dec. 03, 2025 (GLOBE NEWSWIRE) — Internationally acclaimed, multi-platinum singer-songwriter David Pomeranz delivered an uplifting acoustic performance and book talk that brought a renewed spark to a packed audience. Celebrating the silver anniversary of his album “On